Adrenal and Cardiovascular Endocrinology
The ESE Focus Area on Adrenal and Cardiovascular Endocrinology has been created by the European Society of Endocrinology in order to more effectively cover and address the needs within this diverse field.
Adrenal and Cardiovascular Endocrinology is a very dynamic and rapidly growing area. One of our primary objectives within this Focus Area is to promote and facilitate clinical and scientific interactions within the field as well as to disseminate new scientific information.
In order to reach the highest quality of patient care, we will work to promote research activities and the latest clinical developments within the field, while improving communication and collaboration with relevant specialist societies.
Clinical Lead: Eystein Sverre Husebye, Norway
Basic Lead: Maria-Christina Zennaro, France
Expert Panel: Ashley Grossman (UK), Guillaume Assie (France), Eleanor Davies (UK), Ljiljana Marina (Serbia), Carla Scaroni (Italy), Felix Beuschlein (Switzerland), Laurence Amar (France), Irina Chifu (Germany).
ECE 2023
13-16 May
Istanbul, Turkey 25th European Congress of Endocrinology ece2023@endocrinology.orgNews
Latest Focus Area News
- Too much salt may increase stress hormone levels (24 Nov 2022)
- Position statement calls for diabetes insipidus name change to protect patients (20 Oct 2022)
- Oxytocin may stimulate cardiomyocyte regeneration (6 Oct 2022)
- Mineralocorticoid antagonists may be a novel treatment for alcohol use disorder (29 Sep 2022)
Latest ESE News
Read ESE's White Paper
We have released our first policy White Paper
“Hormones in European Health Policies: How endocrinologists can contribute towards a healthier Europe”Guidelines
- European Society of Endocrinology Clinical Practice Guideline: Endocrine-related adverse conditions in patients receiving immune checkpoint inhibition
- European Society of Endocrinology Clinical Practice Guidelines on the management of adrenocortical carcinoma in adults, in collaboration with the European Network for the Study of Adrenal Tumors
- European Society of Endocrinology Clinical Practice Guidelines for the management of Aggressive Pituitary Tumours and Carcinomas
- Management of adrenal incidentalomas: European Society of Endocrinology Clinical Practice Guideline in collaboration with the European Network for the Study of Adrenal Tumours
- European Society of Endocrinology Clinical Practice Guideline for long-term follow-up of patients operated on for a phaeochromocytoma or a paraganglioma
- External Guideline: Diagnosis and treatment of primary adrenal insufficiency: an endocrine society clinical practice guideline
- External Guideline: ENETS consensus guidelines update for gastroduodenal neuroendocrine neoplasms
- External Guideline: MANAGEMENT OF ENDOCRINE DISEASE: Imaging for the diagnosis of malignancy in incidentally discovered adrenal masses: a systematic review and meta-analysis
- External Guideline: ENETS consensus guidelines update for the management of patients with functional pancreatic neuroendocrine tumors and non-functional pancreatic neuroendocrine tumours
- External Guideline: Cancers of unknown primary site: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
- External Guideline: ENETS consensus guidelines for high-grade gastroenteropancreatic neuroendocrine tumors and neuroendocrine carcinomas
- External Guideline: Role of hepatic intra‐arterial therapies in metastatic neuroendocrine tumours (NET): guidelines from the NET‐Liver‐Metastases Consensus Conference
ESE on Demand
Explore content and highlights from ECE 2022 - filtered by your Focus Area
Plus all content from ECE congresses